| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.009 |